Braidwell Co-Founder and Chief Investment Officer Alex Karnal shares his insights on the future of healthcare.
The conversation covers a range of topics including the emerging opportunity at the intersection of AI and drug development and how each of us might think about driving our own personal Health Stack.
Watch at Invest Like the Best
In TIME, our Co-Founders Brian Kreiter and Alex Karnal write about what they are seeing firsthand in drug development, and why this moment is giving us increased reason to be optimistic about the fight against disease and what that could mean for the world our children inherit.
Braidwell Co-Founder and Chief Investment Officer Alex Karnal recently joined Bloomberg TV's The Pulse to discuss how the thoughtful integration of world-class human intelligence and artificial intelligence are transforming healthcare investing and the development of new medicines. Karnal highlighted Switchyard, Braidwell's proprietary AI investment system, and explored how AI has the potential to bring faster and better cures to patients.
